InsidersTradesSigma
Ambea AB ( publ ) Stock: price and management transactions · Finland · FIN-FSA
Follow the Ambea AB ( publ ) stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Ambea AB ( publ ) has published 103 reports. Market capitalisation: €12.5bn. The latest transaction was disclosed on 1 July 2026 (Purchase). Among the most active insiders: Mark Jensen. Every trade is openly available.
In the last 90 days, Ambea AB (publ) reported a total of 75 insider trading declarations. The total amount of shares bought was approximately 164,103 EUR, while the total amount sold was around 297,204,097 EUR. The top insiders included Mark Jensen, the CEO, with a total of approximately 346,498,540 EUR from 19 declarations, Benno Eliasson, the CFO, with about 106,546,105 EUR from 18 declarations, and Fredrik von Malmborg, another executive, with around 48,888,215 EUR from 18 declarations. Notable recent declarations on May 19, 2026, included multiple sales and other transactions by Mark Jensen, Benno Eliasson, and Fredrik von Malmborg, among others.
Auto-generated summary, refreshed daily.Updated 2d ago
103
Insider Decl.
0
Thresholds
€2m
30 ops.
Buy Volume
€298m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ambea AB ( publ ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 174.00.
55Σ signal
Fundamental score
Ranked 4,879 of 25,577 companies
67.5
score / 100
Value74
Quality61
FCF yld16%
Earn yld5.3%
EV/EBITDA8.8x
ROE14%
Gross mgn97%
Net mgn4.1%
Debt/EBITDA4.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations103 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
700 shares@ SEK 148.500.0001% mcap10.8% of flowAktieFI:csv-a7bf7811201fa9024ec3
Ideal exit: 26 Mar 2027 (T+270)
678 shares@ SEK 147.3480.0001% mcap27.4% of flowAktieFI:csv-3d9aae899606cca1a7a4
Ideal exit: 26 Mar 2027 (T+270)
1,740 shares@ SEK 146.200.0002% mcap100.0% of flowAktieFI:csv-3f8bb293c31943032215
Ideal exit: 26 Mar 2027 (T+270)
3,000 shares@ SEK 144.40050.0003% mcap0.0% of flowAktieFI:csv-189684f34c497a0b67c1
Ideal exit: 26 Mar 2027 (T+270)
6,500 shares@ SEK 144.500.0008% mcap0.0% of flowAktieFI:csv-76ad6954efb7921c99c4
Ideal exit: 26 Mar 2027 (T+270)
64,052 shares0AktieFI:csv-57e20bb79b868e740256
64,052 shares0AktieFI:A003Z063-1
5,765 shares0AktieFI:csv-f25c53572eec7ee0d128
5,765 shares0AktieFI:A003Z048-1
12,811 shares0AktieFI:csv-b17280fa68146b159eb2
38,431 shares0AktieFI:csv-73ccdfe0aa6115559c31
38,431 shares0AktieFI:A003Z003-1
12,811 shares0AktieFI:A003Z041-1
12,811 shares@ SEK 4.580.0058% mcap1.3% of flowTeckningsoptionFI:csv-b2a47f982e38423e5487
12,811 shares0AktieFI:csv-38d4c648e3009981b9fa
12,811 shares@ SEK 141.800.18% mcap40.6% of flowAktieFI:csv-7f07873da8784a4684aa
12,811 shares@ SEK 100.360.13% mcap28.7% of flowAktieFI:csv-65ed3629f36c2d3dc2a6
7,765 shares@ SEK 4.580.0035% mcap1.1% of flowTeckningsoptionFI:csv-b90e3b6e3ea740e8786d
7,189 shares0AktieFI:csv-2e0f27bfa6e73d7c128f
5,765 shares@ SEK 141.800.080% mcap25.0% of flowAktieFI:csv-52826a8500e4a38c92d8
5,765 shares0AktieFI:csv-a8f8ed1e1cb478ea2a54
7,765 shares@ SEK 100.360.076% mcap23.8% of flowAktieFI:csv-c6989b2066a62e55db8f
64,052 shares@ SEK 100.360.63% mcap20.2% of flowAktieFI:csv-e2a74528f5f48bfa6242
64,052 shares@ SEK 141.800.89% mcap28.6% of flowAktieFI:csv-026d9aa61ece629c0b32
64,052 shares0AktieFI:csv-d81c12fde201e7198427
25 of 103 declarations
About Ambea AB ( publ )
Ambea AB is a Swedish company that specializes in healthcare services and support for individuals with specific needs. It is listed on the Stockholm Stock Exchange (XSTO).
